Document is current

Article History

Received: 9 February 2026

Accepted: 10 February 2026

First Online: 5 March 2026

Declarations

:

: AF-M has received speaker fees and had attended an advisory board for Pierre Fabre and AstraZeneca; has received speaker fees from Lilly, Servier, Amgen, MSD and Seagen; and has attended an advisory board for Bayer and Mundipharma. JA has received speaker fees from Amgen, Merck and Servier and congress support from Amgen, Merck, Takeda, and MSD. ABC has received speaker fees from AstraZeneca, Lilly, Novartis, and Ipsen and has attended an advisory board for BMS, MSD, BeOne, and Astellas. JGP has received speaker and other fees and has attended an advisory board for Eli Lilly; received other fees and has attended an advisory board for BMS and Servier; and has attended an advisory board for MSD. FR has received speaker fees and has attended an advisory board for Roche, BMS, Sanofi, Amgen, Merck-Serono, and Lilly; has received speaker fees and grants; and has attended an advisory board for MSD, Servier, and AstraZeneca. MA has received speaker fees and has attended an advisory board for BMS, MSD, Lilly, and Servier and has received speaker fees from Amgen and Roche. LFF, CGM, and PR have nothing to disclose.

: Not applicable.

: The manuscript does not contain clinical studies or patient data.